Heska Corporation Fourth Quarter and Full-Year 2020 Financial Results and Earnings Call Scheduled for February 23, 2021
Heska Corporation (NASDAQ: HSKA) will report its Q4 and full-year 2020 financial results on February 23, 2021, before market opening. An earnings call is scheduled for 9 a.m. MT / 11 a.m. ET to discuss the results. The call can be accessed via phone or through a live webcast on the company's investor relations website. A replay will be available after the call. Heska specializes in advanced veterinary diagnostic products across North America and internationally, providing various healthcare solutions.
- None.
- None.
LOVELAND, Colo., Jan. 26, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading provider of advanced veterinary diagnostic and specialty products, plans to report its fourth quarter and full-year 2020 financial performance in a press release before the market opens on Tuesday, February 23, 2021 and to host an earnings call to discuss the results following the release at 9 a.m. MT / 11 a.m. ET.
To access the conference call:
From within the United States, please dial 1-800-289-0438
From outside of the United States, please dial 1-323-794-2423
Reference Conference ID: 2578626
The earnings call will be webcast live from the Company's investor relations website at: Heska Fourth Quarter and Full-Year 2020 Earnings Call Webcast.
A telephonic replay will be available at 2 p.m. ET on February 23 through 11:59 p.m. ET on Tuesday, March 9, 2021 and the webcast will be archived on the Company's website for 90 days.
To access the replay:
From within the United States, please dial 1-844-512-2921
From outside the United States, please dial 1-412-317-6671
Reference Replay Pin Number: 2578626
About Heska
Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production under third-party agreements and channels, primarily for herd animal health.
View original content to download multimedia:http://www.prnewswire.com/news-releases/heska-corporation-fourth-quarter-and-full-year-2020-financial-results-and-earnings-call-scheduled-for-february-23-2021-301214825.html
SOURCE Heska Corporation
FAQ
When will Heska Corporation report its Q4 and full-year 2020 financial results?
What time is the earnings call for Heska's Q4 2020 results?
How can I access the earnings call for Heska Corporation?
Will there be a replay available for Heska's earnings call?